Chile vs Iraq: Rate of new tuberculosis cases
Chile
19 cases per 100,000 people
in 2024
Iraq
21 cases per 100,000 people
in 2024
Chile rank
130th
Iraq rank
127th
Rate of new tuberculosis cases over time
- Chile
- Iraq
How they compare
Iraq currently reports 21 cases per 100,000 people against 19 cases per 100,000 people in Chile, a difference of 2 cases per 100,000 people.
That makes Iraq's figure about 1.1 times Chile's.
Across all 25 years both countries report, Iraq has been ahead every year.
Chile ranks 130th and Iraq ranks 127th of 215 countries.
Iraq has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.5 cases per 100,000 people | 54.6 cases per 100,000 people | 31.1 cases per 100,000 people | Iraq |
| 2010s | 18.2 cases per 100,000 people | 34.1 cases per 100,000 people | 15.9 cases per 100,000 people | Iraq |
| 2020s | 17.8 cases per 100,000 people | 21 cases per 100,000 people | 3.2 cases per 100,000 people | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher rate of new tuberculosis cases, Chile or Iraq?
- Iraq, at 21 cases per 100,000 people against 19 cases per 100,000 people in Chile as of 2024.
- What is the difference in rate of new tuberculosis cases between Chile and Iraq?
- 2 cases per 100,000 people, with Iraq ahead.
- How many years of comparable data are there for Chile and Iraq?
- 25 years are reported by both, from 2000 to 2024.
- How do Chile and Iraq rank globally for rate of new tuberculosis cases?
- Chile ranks 130th and Iraq ranks 127th of 215 countries.
- Where does this data come from?
- WHO (2025); Population based on various sources (2024) – with minor processing by Our World in Data, published as Rate of new tuberculosis cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of new cases of tuberculosis per 100,000 people.